Reversible hematologic suppression during ranitidine treatment.
Bader
A
A
Carrigan
T
T
Gopalswamy
N
N
Trulzsch
D V
DV
D000380:Agranulocytosis / Q000139:chemically induced*; D001772:Blood Cell Count; D001831:Body Temperature / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011899:Ranitidine / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*; D013997:Time Factors
D011899:Ranitidine